U.K. Hospitality Stock News

Why GSK stock is on investors’ radar today GSK (LSE:GSK) has been drawing attention after a period of mixed share performance, with a 1 day return of 1.83% alongside a 7 day decline of 7.41% and a modest month fall of 2.02%. Over longer periods, the stock shows a 12.9% gain in the past 3 months, 11.27% year to date and a 38.25% total return over 1 year, with 3 year and 5 year total returns of 64.24% and 97.99% respectively. See our latest analysis for GSK. At a share price of £20.38, GSK has...

Shell (LSE:SHEL) is planning a capital injection into Raizen in Latin America, along with a potential restructuring of the joint venture ownership. The company has entered new oil and gas agreements in Venezuela and Kazakhstan as part of upstream exploration and energy cooperation efforts. Shell has agreed with METLEN to expand LNG supply and use of the European Vertical Gas Corridor in Southeast Europe. Shell, a global energy group active in oil, gas, LNG and biofuels, now has several...

BP has begun shutting down production at the Rumaila oil field in Iraq due to onshore storage constraints and tanker delays in the Persian Gulf. The company is facing tanker traffic bottlenecks that are affecting crude liftings and near term output from one of its largest fields. Separately, BP has secured an arbitration win against Venture Global LNG over sales from the Calcasieu Pass plant, with multibillion pound damages pending. LSE:BP enters this phase of disruption and legal repricing...

Barclays share performance and recent context Barclays (LSE:BARC) has drawn investor attention after a mixed run in its share performance, with the stock showing a negative move over the past month but a positive total return over the past year. For context, the shares show a 17% decline over the past month and a 4% decline over the past 3 months. The 1 year total return figure sits at 38%. That backdrop frames how some investors are thinking about the bank’s current valuation and its recent...

British American Tobacco (LSE:BATS) is facing a new lawsuit in London from shareholders. The claim focuses on alleged nondisclosure of breaches of U.S. sanctions linked to business dealings in North Korea. Shareholders allege they were not fully informed about material regulatory issues following a prior sanctions settlement. The case raises questions about the company’s governance, disclosure practices, and potential legal liabilities. British American Tobacco, the multinational tobacco...

Why Unilever is on investors’ radar today Unilever (LSE:ULVR) has been drawing attention after recent share price moves, with the stock showing mixed short term returns but positive performance over the past year and multi year period. For context, the shares are around £51.15, with a 1 day return of about 0.4% decline and a 7 day return of roughly 5.3% decline, while the month and past 3 months show gains of 2.5% and 2.7% respectively. See our latest analysis for Unilever. Recent share price...

If you are wondering whether British American Tobacco is still attractively priced after a strong run, this article walks through what the current share price might be implying about long term value. The stock has returned 57.1% over the past year and 8.1% year to date, with a recent 2.1% gain over 30 days despite a 1.9% pullback in the last week, which may signal changing views on both its potential and its risks. Recent headlines around British American Tobacco have focused on the broader...

Recent share performance and business snapshot AstraZeneca (LSE:AZN) has seen mixed short term returns, with a 2.1% decline over the past day and a 2.6% pullback over the past week, while the share price is higher over the past month. Over the past 3 months and year to date, the stock has posted positive total returns, alongside a 1 year total return of 25.9%. Over 3 and 5 years, total returns are higher again, reflecting a longer period of shareholder gains. The company reports annual...

How Shell’s recent performance sets the stage for investors Shell (LSE:SHEL) has been on many investors’ radar after a period where the share price showed a mix of short term softness, with a 1 day return of around a 1% decline, and stronger gains over the past month and the past 3 months. See our latest analysis for Shell. With the share price at £31.13, Shell’s recent 1 month share price return of 11.42% and year to date gain of 12.81% contrast with a much stronger 5 year total shareholder...

Fresnillo (LSE:FRES) reported record financial performance for the year, with revenues and profits at all time highs. The company achieved this result despite declines in silver and gold production. Fresnillo also paid its highest dividend since its listing, supported by elevated precious metal prices. Fresnillo is a major precious metals producer, with a core focus on silver and gold. The latest results come at a time when precious metal prices have been elevated, which can have a strong...

HSBC Holdings (LSE:HSBA) has named Dame Carolyn Fairbairn as the next chair of HSBC UK, succeeding the current incumbent after regulatory approvals. The group is also progressing with the sale of its Indonesian consumer banking operations, with several Southeast Asian banks reported to be interested in the assets. These moves come as HSBC continues to refine its global footprint and governance structure across key markets. For investors watching HSBC Holdings at a current share price of...

Recent performance snapshot for BP (LSE:BP.) With no single headline event driving attention, BP (LSE:BP.) has still attracted interest after a period where the shares show a one-month return of 6.30% and a three-month return of 6.25%. See our latest analysis for BP. At a share price of £4.93, BP’s recent share price momentum, with a 7 day share price return of 4.63% and year to date share price return of 12.58%, sits alongside a 1 year total shareholder return of 27.94% and 5 year total...

Diageo (LSE:DGE) has closed its Crown Royal whisky plant in Amherstburg, Ontario, resulting in over 200 job losses with limited notice to staff. Production for Crown Royal is shifting to facilities in the US following the Amherstburg shutdown. The company has cut its interim dividend by around half after reporting disappointing results. Diageo is facing pressure in agave spirits, with weaker sales and a lawsuit challenging the authenticity of Casamigos and Don Julio. Diageo (LSE:DGE) sits...

Rio Tinto has approved the resumption of the Zulti South mineral sands project in South Africa, including a $473m investment. The company is also progressing work on primary gallium extraction in Quebec, supported by research partners and the Canadian government. Both projects are aimed at securing long term supplies of materials used in industrial applications and emerging technologies. Rio Tinto Group (LSE:RIO), trading at around £73.36, sits in the large cap mining space with returns of...

Glencore at a glance: share performance and recent momentum Glencore (LSE:GLEN) has attracted fresh attention after a strong run in recent months, with the share price posting a 7.0% return over the past month and 48.3% over the past 3 months. Over longer periods, the stock shows a 30.7% year to date return and a 69.9% total return over the past year. The 5 year total return stands at 134.1%, suggesting meaningful long term compounding for investors who stayed invested. The company reports...

BAE Systems (LSE:BA) has launched Silver Link™, a new modular antenna portfolio for airborne communications. The company secured a major US Army contract for advanced self-propelled howitzers. BAE Systems reached a production milestone with delivery of its 100,000th APKWS laser guided kit. For investors watching large defense contractors, these three updates give a clearer view of how BAE Systems earns its place in modern military programs. The company is active across precision munitions,...

Barclays (LSE:BARC) is facing potential financial and reputational impact after the collapse of Market Financial Solutions, a specialist mortgage lender. The bank had significant exposure to MFS and identified suspicious activity early, freezing accounts and blocking related transactions ahead of the lender's insolvency. Fraud and irregularity allegations at MFS are prompting fresh scrutiny of underwriting standards and controls in leveraged lending structures and private credit...

If you are wondering whether Shell’s current share price gives you good value or not, you are in the right place to unpack what the market might be pricing in. Shell’s shares last closed at £31.32, with returns of 5.6% over 7 days, 12.1% over 30 days, 13.5% year to date, 22.6% over 1 year and 35.9% over 3 years. This gives you a useful backdrop before comparing the price to underlying value. Recent headlines around Shell have focused on its position in the global energy sector and how...

Wondering if AstraZeneca's current share price reflects its true worth, or if the market is getting ahead of itself? This article is built to help you make sense of the valuation. With the share price at £152.52 and returns of 12.1% over 30 days, 12.2% year to date and 30.4% over 1 year, AstraZeneca has recently seen meaningful moves that can change how investors view its potential and risk. Recent news coverage has focused on AstraZeneca's product pipeline, partnerships and regulatory...

How NatWest Group’s Recent Performance Frames the Investment Question NatWest Group (LSE:NWG) has seen mixed share performance recently, with a 1 day decline and a small gain over the past week, while returns over the month and past 3 months have been negative. At the same time, the bank reports annual revenue of £15,970.0m and net income of £5,479.0m, alongside positive annual revenue and net income growth rates. This gives investors concrete numbers to weigh against recent share price...

GSK (LSE:GSK) is acquiring Canadian biotech 35Pharma in a deal valued at nearly US$1b. The transaction brings 35Pharma’s investigational activin signaling inhibitor HS235 into GSK’s pipeline. HS235 is being developed for pulmonary arterial hypertension and related cardiopulmonary conditions. For GSK, known for its focus on respiratory and specialty medicines, the 35Pharma deal adds another late stage cardiopulmonary asset alongside its existing portfolio. Pulmonary arterial hypertension...

If you are wondering whether Barclays shares still offer value after a strong run, this article will walk through what the current price really implies. The stock has pulled back recently, with a 4.4% decline over the last 7 days and a 5.6% decline over the last month, although the 1 year return sits at 48.4% and the 3 year return at 192.2%. Alongside these recent moves, Barclays has remained in focus for long term investors who are reassessing banks in light of changing interest rate...

If you are wondering whether Fresnillo’s recent share price strength still leaves any value on the table, or if you might be late to the story, this article walks you through what the current market price could be implying. Fresnillo’s shares last closed at £42.40, with returns of 10.0% over the past week, 8.7% over the past month, 26.5% year to date and a very large gain over the past year and past five years based on the data provided. Those moves sit against a backdrop of ongoing interest...

If you are wondering whether Rolls-Royce Holdings is still good value after its run up, this article will walk you through what the current price might be implying about the stock. The share price has been volatile recently, with a 0.2% decline over the last 7 days, a 10.4% gain over the last 30 days, an 11.4% return year to date, an 81.5% return over 1 year, and a very large 3 year and 5 year return that is well above 7x. Recent coverage around Rolls-Royce has focused on its position as a...